Kiniksa Pharmaceuticals International, plc Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $331.00K, a 524.53% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $2.94M, a 473.44% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $2.41M, a 1233.70% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $53.00K, a 10.17% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, stock options exercised for fiscal 2019 was $1.12M, a 196.82% increase from fiscal 2018.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, stock options exercised for fiscal 2018 was $377.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-09-30 | $331.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $2.94M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $2.41M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $1.12M 10-K · filed 2020-03-05 | |
| 2019-09-30 | $53.00K 10-Q · filed 2020-11-05 | $1.05M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $512.00K 10-Q · filed 2020-11-05 | $1.05M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-03-31 | $181.00K 10-Q · filed 2020-11-05 | $541.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2018-12-31 | $301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $377.00K 10-K · filed 2020-03-05 |
| 2018-09-30 | $59.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | |
| 2018-03-31 | $17.00K 10-Q · filed 2019-11-05 |